65,437 trials
Traumatic Brain Injury · Attention Deficit Disorder
Primary: Assessing Severity of Symptoms Associated With Attention-deficit/Hyperactivity Disorder (ADHD) in Children When Using Vyvanse Versus Placebo by Administering the…
Healthy Participants
Primary: Percentage of Participants With Adverse Events (AEs) — 37.5; 37.5; 25.0; 50.0 Percentage of Participants
Vision, Entoptic
Primary: Macular Pigment Optical Density — 0.54; 0.42 optical density — p=0.01
Zika Virus Infection · Zika Virus Disease
Primary: Number of Subjects With Adverse Events. — 12; 8; 0; 0 participants
Alzheimer Disease · Mild Cognitive Impairment · Delirium, Dementia, Amnestic, Cognitive Disorders
Primary: Change Over Time in Selective Reminding Test (SRT) Scores — 36.14; 21.19; 39.99; 24.10 Words
Binge Eating Disorder
Primary: Change From Baseline in Number of Binge Days — -2.92; -3.21; -3.47 binge days/week — p=0.1187
Urinary Tract Infection
Primary: Comparison of Efficacy Based on Symptomatic Urinary Tract Infection (UTI) Between Short-course and Standard-course of Antibiotics. — 2; 14 Participants
Spine Diseases
Primary: Extubation Time — 16.3; 16.6 min
Popliteal Artery Aneurysm
Primary: Number of Subjects With Primary Patency at 12 Months — 40; 11 Participants
Tinnitus
Primary: Tinnitus Questionnaire (TQ) — 34.3; 35.1 score on a scale
Hypoxic-ischemic Encephalopathy · Neonatal Encephalopathy · Birth Asphyxia
Primary: Markers of Organ Function — 10; 6; 9; 12 participants
Non Clear Cell Renal Cell Carcinoma (nccRCC)
Primary: Objective Response Rate (ORR) — 25.8 percentage of participants
Diabetes
Primary: Change in Patient Activation, as Measured by Patient Activation Measure - 13 — 2.94; 1.78 units on a scale — p=0.048
Radiation Exposure · Enteral Nutrition
Primary: Time to Duodenal Intubation — 1.6; 4.1 Minutes
Osteoarthritis, Knee
Primary: Change From Baseline in Cartilage Thickness in the Total Femorotibial Joint as Evaluated by Quantitative Magnetic Resonance Imaging (qMRI) at Year 2 — -0.02; -0.01…